Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Special MTA: Probes for Oncology Posters

  • You have access
    Monitoring bevacizumab therapy with PET/CT and 68Ga-NODAGA-c(RGDfK)
    Svetlana Rylova, Enikö Barnucz, Melpomeni Fani, Friederike Braun, Yvonne Kiefer, Roswitha Toennesmann, Martin Werner, Silke Lassmann and Wolfgang Weber
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1168;
  • You have access
    Automated production of [18F]F- and [18F]FDG at the University of Oklahoma Health Sciences Center (OUHSC)
    Vibhudutta Awasthi, Hariprasad Gali, Aaron McFarland and Atilio Anzellotti
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1166;
  • You have access
    Experimental study of 188Re labeled RGD tumor homing peptide modified recombinant human plasminogen kringle5
    Rui Guo, Sheng Liang, Yufei Ma and Biao Li
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1183;
  • You have access
    Gelofusine reduces kidney uptake of [Lys40-(Ahx-HYNIC)NH2-99mTc]exendin-4
    Renata Mikolajczak, Barbara Janota, Urszula Karczmarczyk, Alicja Hubalewska-Dydejczyk, Anna Sowa-Staszczak, Monika Tomaszuk and Piotr Garnuszek
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1162;
  • You have access
    Production of Cu-64 using a solution target
    Hendrik Engelbrecht, John Byrne, Alan Packard, Mukesh Pandey, James Gruetzmacher and Timothy DeGrado
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1175;
  • You have access
    Molecular imaging probes targeting NPY Y1: Synthesis, structure-activity relationship and radiolabeling of potent and selective small molecules
    T. Wu, Jennifer Lemon, Jason Chio, Ryan Simms, John Forbes, Sean Collens, Cyrille Gineste, Karin Stephenson and John Valliant
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1180;
  • You have access
    Asiaticoside suppresses in vivo 7,12 dimethyl benzanthracene (DMBA)-induced mammary carcinogenicity in rats and MCF-7 cells proliferation
    Fatma Al-Saeedi
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1182;
  • You have access
    64Cu-lactosaminated human serum albumin enhanced the targeting ability to asialoglycoprotein receptor positive cells dependent on additional lactosamine residues
    Myung Geun Song, Sol-Ah Jang, Hyewon Youn, Yun-Sang Lee, Jae Min Jeong, Dong Soo Lee, June-Key Chung, Felix Kratz and Keon Wook Kang
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1176;
  • You have access
    Design and initial evaluation of USPIO modified bevacizumab as a hybrid SPECT/MRI probe to hepatoma carcinoma cells
    Dengfeng Cheng, Yanzhao Zhao, Qi Yao, Hui Tan, Bing Wu, Peng-yue Wu, Chunfu Zhang and Hongcheng Shi
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1169;
  • You have access
    Synthesis and evaluation of radiolabeled oleanolic acid for diagnosis of colon cancer using PET
    Eun Kyoung Ryu, Sung-Min Kim and Min Su Yim
    Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 1178;

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 16
SNMMI

© 2025 SNMMI

Powered by HighWire